Annual report pursuant to Section 13 and 15(d)

Subsequent Events

v3.6.0.2
Subsequent Events
12 Months Ended
Dec. 31, 2016
Subsequent Events  
Subsequent Events

16. Subsequent Event

TMRC Co. Ltd

 

In March 2017, the Company paid TMRC approximately $0.4 million for the production of SY-1425 active pharmaceutical ingredient under the supply management agreement with TMRC.